NVM invests £3 million in Cleveland Biotech

June 19, 2013 |

In the United Kingdom, NVM Prive Equity has invested £3 million to support the £4.4 million management buy-out of Cleveland Biotech, a provider of environmentally friendly biological waste treatment products. The change in ownership will allow the management team to build the business organically, taking advantage of the significant growth potential in existing and new markets across Europe. “This is a very interesting sector to invest into right now as FOG management expenditure steadily increases in order to avoid legislative penalties,” stated Mauro Biagioni, Director of NVM Private Equity.

Category: Fuels

Thank you for visting the Digest.